This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

Trump directed a panel headed by HHS Secretary Robert F. Kennedy Jr. to assess “the prevalence of and threat” posed by SSRIs, ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Not all weight loss programs are made equal—to reach a healthy, sustainable weight, personalized programs offer the best ...

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic ...

Doctors at the University of Utah’s Moran Eye Center have reviewed cases of nine patients who developed vision problems while ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and ...

Eli Lilly inked two collaborations on Monday, one focused on cardiometabolic diseases with South Korea’s OliX Pharmaceuticals ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...